酯酶抑制劑 的英文怎麼說

中文拼音 [zhǐyìzhìjì]
酯酶抑制劑 英文
pcesterase inhibitors
  • 酯 : 名詞[化學] （有機化合物的一類） ester
  • 酶 : 名詞[生物化學] （生物體的細胞產生的有機膠狀物質） enzyme; ferment
  • 抑 : Ⅰ動詞（向下按; 壓制） restrain; repress; curb Ⅱ連詞[書面語]1 （表示抉擇） or 2 （表示轉折） but3 ...
  • 制 : Ⅰ動詞1 （製造） make; manufacture 2 （擬訂; 規定） draw up; establish 3 （用強力約束; 限定; 管束...
  • 劑 : Ⅰ名詞1 （藥劑; 制劑） a pharmaceutical or other chemical preparation 2 （某些有化學作用的物品） a...
  • 抑制 : 1 （控制） restrain; control; check; hold up; curb; stop; repress; bridle; choke; prehension; sup...
  1. A surprisingly low seropositivity rate of anti - acetylcholine - receptor antibodies ( 1 / 7 ) and anti - musk ( muscle specific kinase ) antibodies ( 0 / 6 ) were found in these dysphonia mg patients

    該診斷在新斯的明（膽堿酯酶抑制劑）試驗陽性之前或之後通過纖維喉鏡檢查和聲學分析而被確定。
  2. Protein kinase a is camp - dependent kinase, one of the most important signal transduction pathways, plays a pivotal role in growth, differentiation, tumor occur, cell cycle control, etc. pka activators such as camp, 8 - br - camp or phosphodiesterase ( pde ) inhibitor isomethyl butyl xanthine ( imbx ) or purified pka catalytic subunit all can inhibit germinal vesicle breakdown ( gvbd ) and meiotic maturation in mouse oocytes, also in xenopus oocytes

    蛋白激酶a （ proteinkinasea ， pka ）是依賴于camp的絲蘇氨酸蛋白激酶，是重要的信號傳導途徑之一，廣泛參與許多生命過程，包括生長、分化、腫瘤發生、細胞凋亡、細胞周期調控等。以小鼠卵母細胞為實驗對象，給予pka激動劑camp 、 8 - br - camp或磷酸二酯酶抑制劑imbx （ isomethylbutylxanthine ）均可抑制小鼠卵母細胞的胚泡破裂及減數分裂成熟。
  3. Vanadate, a potent ptpase inhibitor, locks adipocyte differentiation at an early stage in the program and leds to the accumulation of p - c - crkii, a phosphotyrosyl protein that is a substrate for ptpase ha2

    研究發現一種強烈的磷酸酯酶抑制劑- -釩酸鈉能夠作用於脂肪細胞的分化早期過程從而抑制其分化，並使一種ptpha2的底物即酪氨酸磷酸化的蛋白質p - c - crkii累積。
  4. Isozyme patterns of the gill is difference from the hepatopancreas, they had two steady identical basic isozyme bands at 0. 34 and 0. 76 of rf value, but the activation is changed

    結果表明，銅、鎘聯合作用對長江華溪蟹酯酶同工酶的活性既有激活作用又有抑制作用，存在組織差異性並且存在劑量?效應關系。
  5. The results showed that the effects of pb + on esterase isoenzyme activity are not only the activation but the inhibity as well. there were different effects of pb2 + on est isoenzyme of the major tissues

    結果表明：鉛對長江華溪蟹酯酶同工酶的活性影響既有激活作用又有抑制作用，並存在組織差異性和劑量效應。
  6. " the concept is that systemic sclerosis, which is a severe disease characterized by systemic fibrosis, is at the beginning mainly a vascular disease, and we hypothesize that using major vascular drugs ( calcium channel blockers, endothelin antagonists, prostacyclins, phosphodiesterase inhibitors, etc. ) from the beginning and at appropriate dosage may interfere with the fibrotic process which seems secondary, " dr

    「從概念上講，系統性硬化是一種以系統性的纖維化變性為特徵的嚴重疾病，早期主要表現在血管性的病變，因此我們推測早期、適量地應用主要作用於血管的藥物（如鈣離子阻斷劑，內皮素拮抗劑，前列環素，磷酸二酯酶抑制劑等）可能可以干預似乎是繼發發生的纖維化過程。 」
  7. " the concept is that systemic sclerosis, which is a seere disease characterized by systemic fibrosis, is at the beginning mainly a ascular disease, and we hypothesize that using major ascular drugs ( calcium channel blockers, endothelin antagonists, prostacyclins, phosphodiesterase inhibitors, etc. ) from the beginning and at appropriate dosage may interfere with the fibrotic process which seems secondary, " dr

    「從概念上講，系統性硬化是一種以系統性的纖維化變性為特徵的嚴重疾病，早期主要表現在血管性的病變，因此我們推測早期、適量地應用主要作用於血管的藥物（如鈣離子阻斷劑，內皮素拮抗劑，前列環素，磷酸二酯酶抑制劑等）可能可以干預似乎是繼發發生的纖維化過程。 」
  8. Huperzine a has been shown to be a powerful selective inhibitor of acetylcholinesterase and has attracted widespread attention because of its unique pharmacological profile and low toxicity

    石杉鹼甲是一高效、高選擇性乙酰膽鹼酯酶抑制劑，由於其獨特的藥理特徵和低毒性，引起了人們的廣泛注意。
  9. Several acetylcholinesterase inhibitors have been authorized for alzheimef ' s disease ( ad ) therapy during recent years

    摘要近年來已有多個膽堿酯酶抑制劑被批準用於治療阿爾采末病。
  10. Abstract : huperzine a has been shown to be a powerful selective inhibitor of acetylcholinesterase and has attracted widespread attention because of its unique pharmacological profile and low toxicity

    文摘:石杉堿甲是一高效、高選擇性乙酰膽堿酯酶抑制劑，由於其獨特的藥理特徵和低毒性，引起了人們的廣泛注意。
  11. ( 3 ) treatment of naf, a common inhibitor of phosphatasescarried out while light - induced recovery can not prevent dl aggregators from being deaggregated but inhibit p - d1 dephosphorylated and dephosphorylated dl degradated

    （ 3 ）若在弱光恢復前加入蛋白磷酸酯酶抑制劑naf ，聚合物仍然減少，但磷酸化d1蛋白量和d1蛋白總量幾乎不變。
  12. Calcineurin inhibitor minimization and addition of mycophenolate mofetil ( mmf ) or sirolimus have shown variable improvements in renal function, though suboptimal efficacy and safety with the currently proposed regimes have limited their application

    鈣調磷酸酶抑制劑最小化以及附加麥考酚酸莫酯（ mmf ）或西羅莫司，已經展現出不定的改善腎功能的作用，雖然欠佳的療效和安全性以及當前提出的管理體制限制了它們的應用。
分享友人
分享到 Line

分享到臉書